Walking Fish Therapeutics
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
280 Utah Ave Ste 250, South San Francisc...Phone Number
(650) 392-0422Website
www.walkingfishtx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Walking Fish Therapeutics
Walking Fish has created a broad B cell platform for oncology, regenerative medicine, autoimmune disease, and recombinant antibody production. As a leader in B cell engineering, Walking Fish has made critical advances in engineering technologies and has a deep understanding of B cell biology. The company was founded in 2018 and is headquartered in South San Francisco, California.Explore more
Walking Fish Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Walking Fish Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Walking Fish Therapeutics launches new products
Congratulate Masked Content for being promoted to Masked Content at Walking Fish Therapeutics
Funding: Get notified immidiatlly once Walking Fish Therapeutics has new funding data
Check if Walking Fish Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Walking Fish Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Click to see if Walking Fish Therapeutics had a recent Job posting/layoffs
Earning: See what the market has to say on Walking Fish Therapeutics recently announced quarterly report
Check out if Walking Fish Therapeutics is spiking on competitors!
Recommended Actions
Find VP level buyers at Walking Fish Therapeutics
Find more new buyers
Compare Similar Companies to Walking Fish Therapeutics
Compare insights from companies similar to Walking Fish Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Walking Fish Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Walking Fish Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Walking Fish Therapeutics.
Walking Fish Therapeutics financials insights
Gather financial insights about Walking Fish Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$150K
2022
Series A
$73M
Walking Fish Therapeutics Tech Stack
A closer look at the technologies used by Walking Fish Therapeutics
Most Recent Scoops
Promotion
Executive Move
Walking Fish Therapeutics has announced that Julie Kim has been promoted from Senior VP, Corporate Strategy & Business Development to the role of Chief Business Officer.
New Hire
Executive Move
Funding
Funding
Walking Fish Therapeutics News & Media
MaxCyte Signs Strategic Platform License with Walking Fish Therapeutics to Support the Development of its Innovative B Cell Platform
Walking Fish to use MaxCyte’s Flow Electroporation® technology and ExPERT™ platform to engineer novel B-cell based medicines for the treatment of serious diseases Walking Fish to use MaxCyte’s Flow Electroporation® technology and ExPERT™ platform to engineer novel B-cell based medicines for the treatment of serious diseasesWalking Fish Therapeutics Expands Leadership Team and Debuts New Headquarters as it Advances Its B Cell Therapeutics Towards Clinical Trials
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Walking Fish Therapeutics, a leader in B cell engineering, today announced it has appointed Georgia Erbez as Chief Operating Officer and moved to a new 22,000 square foot office and world-class laboratory in South San Francisco. “Walking Fish is at a pivotal point as we move the first of our B cell therapies towards clinical trials. Our platform is generating candidates in the fields of oncology, rare disease, and regenerative medicine,”Walking Fish Therapeutics Closes $73 Million Series A Financing
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Walking Fish Therapeutics, a leader in B cell therapeutics, today announced the completion of an oversubscribed Series A financing, raising a total of $73 million. The additional investment, co-led by Northpond Ventures and First Spark Ventures, with support from Terra Magnum Capital Partners, will be used to advance a pipeline of B cell therapeutics for oncology, rare disease, regenerative medicine, autoimmune disease, and recombinant antibody prodWalking Fish Therapeutics Raises $50M in Series A Financing
Walking Fish Therapeutics, a South San Francisco, CA-based B cell engineering company, closed a $50M Series A financing. The round was led led by Emerson Collective, Illumina Ventures and Quan Capital. Co-founded by CEO Dr. Lewis “Rusty” Williams and Dr. Mark Selby, co-inventor of the immuno-oncology drug OPDIVO and multiple others, Walking Fish Therapeutics develops […] The post Walking Fish Therapeutics Raises $50M in Series A Financing appeared first on FinSMEs.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Walking Fish Therapeutics
Sign Up For FreeTo access detailed company insights
Walking Fish has created a broad B cell platform for oncology, regenerative medicine, autoimmune disease, and recombinant antibody production. As a leader in B cell engineering, Walking Fish has made critical advances in engineering technologies and has a deep understanding of B cell biology. The company was founded in 2018 and is headquartered in... Read More
